Limitations	NNS	_ <O>
to	IN	_ <O>
the	DT	_ <O>
widespread	JJ	_ <O>
use	NN	_ <O>
of	IN	_ <O>
PET	NNP	_ <O>
arise	VBP	_ <O>
from	IN	_ <O>
the	DT	_ <O>
high	JJ	_ <O>
costs	NNS	_ <O>
of	IN	_ <O>
cyclotrons	NNS	_ <O>
needed	VBN	_ <O>
to	TO	_ <O>
produce	VB	_ <O>
the	DT	_ <O>
short	JJ	_ <O>
-	HYPH	_ <O>
lived	VBN	_ <O>
radionuclides	NNS	_ <O>
for	IN	_ <O>
PET	NNP	_ <O>
scanning	NN	_ <O>
and	CC	_ <O>
the	DT	_ <O>
need	NN	_ <O>
for	IN	_ <O>
specially	RB	_ <O>
adapted	VBN	_ <O>
on	IN	_ <O>
-	HYPH	_ <O>
site	NN	_ <O>
chemical	NN	_ <O>
synthesis	NN	_ <O>
apparatus	NN	_ <O>
to	TO	_ <O>
produce	VB	_ <O>
the	DT	_ <O>
radiopharmaceuticals	NNS	_ <O>
.	.	_ <O>
 <O>
Few	JJ	<B-CUE>
hospitals	NNS	<I-CUE>
and	CC	<I-CUE>
universities	NNS	<I-CUE>
are	VBP	_ <O>
capable	JJ	_ <O>
of	IN	_ <O>
maintaining	VBG	_ <O>
such	JJ	_ <O>
systems	NNS	_ <O>
,	,	_ <O>
and	CC	_ <O>
most	JJS	<B-CUE>
clinical	JJ	<I-CUE>
PET	NN	<I-CUE>
is	VBZ	_ <O>
supported	VBN	_ <O>
by	IN	_ <O>
third	JJ	_ <O>
-	HYPH	_ <O>
party	NN	_ <O>
suppliers	NNS	_ <O>
of	IN	_ <O>
radiotracers	NNS	_ <O>
which	WDT	_ <O>
can	MD	_ <O>
supply	VB	_ <O>
many	JJ	<B-CUE>
sites	NNS	<I-CUE>
simultaneously	RB	_ <O>
.	.	_ <O>
 <O>
This	DT	_ <O>
limitation	NN	_ <O>
restricts	VBZ	_ <O>
clinical	JJ	_ <O>
PET	NNP	_ <O>
primarily	RB	_ <O>
to	IN	_ <O>
the	DT	_ <O>
use	NN	_ <O>
of	IN	_ <O>
tracers	NNS	_ <O>
labelled	VBN	_ <O>
with	IN	_ <O>
F-18	NNP	_ <O>
,	,	_ <O>
which	WDT	_ <O>
has	VBZ	_ <O>
a	DT	_ <O>
half	JJ	_ <O>
life	NN	_ <O>
of	IN	_ <O>
110	CD	_ <O>
minutes	NNS	_ <O>
and	CC	_ <O>
can	MD	_ <O>
be	VB	_ <O>
transported	VBN	_ <O>
a	DT	_ <O>
reasonable	JJ	_ <O>
distance	NN	_ <O>
before	IN	_ <O>
use	NN	_ <O>
,	,	_ <O>
or	CC	_ <O>
to	IN	_ <O>
rubidium-82	NNP	_ <O>
,	,	_ <O>
which	WDT	_ <O>
can	MD	_ <O>
be	VB	_ <O>
created	VBN	_ <O>
in	IN	_ <O>
a	DT	_ <O>
portable	JJ	_ <O>
generator	NN	_ <O>
and	CC	_ <O>
is	VBZ	_ <O>
used	VBN	_ <O>
for	IN	_ <O>
myocardial	JJ	_ <O>
perfusion	NN	_ <O>
studies	NNS	_ <O>
.	.	_ <O>
 <O>
Nevertheless	RB	_ <O>
,	,	_ <O>
in	IN	_ <O>
recent	JJ	_ <O>
years	NNS	_ <O>
a	DT	_ <O>
few	JJ	_ <O>
on	IN	_ <O>
-	HYPH	_ <O>
site	NN	_ <O>
cyclotrons	NNS	_ <O>
with	IN	_ <O>
integrated	VBN	_ <O>
shielding	VBG	_ <O>
and	CC	_ <O>
hot	JJ	_ <O>
labs	NNS	_ <O>
have	VBP	_ <O>
begun	VBN	_ <O>
to	TO	_ <O>
accompany	VB	_ <O>
PET	NNP	_ <O>
units	NNS	_ <O>
to	IN	_ <O>
remote	JJ	_ <O>
hospitals	NNS	_ <O>
.	.	_ <O>
 <O>
